News

Pharmabiz10m
Cerevance to present data of KCNK13 inhibitor at Alzheimer’s Association International Conference 2025
Cerevance, a clinical-stage biopharmaceutical company advancing multiple cell type-specific therapies for the treatment of neurodegenerative diseases and obesity, announced upcoming presentations at ...
Pharmabiz6h
Ayush and herbal products exports grew 0.5 per cent in May
Export of Ayush and herbal products has reported a marginal growth of 0.5 per cent during the month of May, as compared to ...
Pharmabiz1h
Agilus Diagnostics launches new Anti-MCV antibody test that provides early RA diagnosis, improves patient outcomes
Agilus Diagnostics launches new Anti-MCV antibody test that provides early RA diagnosis, improves patient outcomes: Our Bureau, Bengaluru Tuesday, July 15, 2025, 12:15 Hrs [IST] A ...
Pharmabiz2h
BriaCell Therapeutics Corporation announces updated phase 2 data of Bria-IMT, shows survival advantage over Trodelvy in metastatic breast cancer
BriaCell Therapeutics Corporation announces updated phase 2 data of Bria-IMT, shows survival advantage over Trodelvy in metastatic breast cancer: Philadelphia & Vancouver, British ...
Pharmabiz1h
ViiV & MPP extend voluntary licensing long-acting injectable HIV treatment, Indian pharma to benefit
ViiV & MPP extend voluntary licensing long-acting injectable HIV treatment, Indian pharma to benefit: Our Bureau, Bengaluru Tuesday, July 15, 2025, 12:45 Hrs [IST] ViiV Healthcare ...
Pharmabiz1h
Arcus Biosciences’ quemliclustat receives US FDA orphan drug designation to treat pancreatic cancer
Arcus Biosciences’ quemliclustat receives US FDA orphan drug designation to treat pancreatic cancer: Hayward, California Tuesday, July 15, 2025, 13:00 Hrs [IST] Arcus Bioscience ...
Pharmabiz4h
Study says India’s healthcare set for $50 billion transformation as single-specialty hospitals surge
Study says India’s healthcare set for $50 billion transformation as single-specialty hospitals surge: Our Bureau, Mumbai Tuesday, July 15, 2025, 10:00 Hrs [IST] India’s health ...
Pharmabiz3h
Elegen, Nutcracker Therapeutics to pilot cell-free manufacturing process for RNA-based personalized cancer therapeutics
Elegen, Nutcracker Therapeutics to pilot cell-free manufacturing process for RNA-based personalized cancer therapeutics: San Francisco Tuesday, July 15, 2025, 11:00 Hrs [IST] Eleg ...
Pharmabiz3h
Sun Pharma launches Leqselvi in US for treatment of severe alopecia areata
Sun Pharmaceutical Industries Limited announced Leqselvi (deuruxolitinib) 8 mg tablets is now available to healthcare providers and people living with severe alopecia areata in the US. Leqselvi is ...
Pharmabiz5h
Verastem Oncology releases primary results from phase 2 RAMP 201 trial of Avutometinib in combo with defactinib
Verastem Oncology releases primary results from phase 2 RAMP 201 trial of Avutometinib in combo with defactinib: Boston Tuesday, July 15, 2025, 09:00 Hrs [IST] Verastem Oncology, ...
Pharmabiz6h
India’s global pharma status hinges on regulatory strengthening: Dr Chandrashekar Ranga
India’s global pharma status hinges on regulatory strengthening: Dr Chandrashekar Ranga: Nandita Vijayasimha, Bengaluru Tuesday, July 15, 2025, 08:00 Hrs [IST] Strengthening Ind ...
Pharmabiz6h
Improving antimicrobial stewardship through novel anti-infectives is the need of the hour: Dr Surendran
Improving antimicrobial stewardship through novel anti-infectives is the need of the hour: Dr Surendran: Shardul Nautiyal, Mumbai Tuesday, July 15, 2025, 08:00 Hrs [IST] Improving ...